CN112798377A - 一种荧光淬灭恢复剂及其应用 - Google Patents
一种荧光淬灭恢复剂及其应用 Download PDFInfo
- Publication number
- CN112798377A CN112798377A CN202110125784.0A CN202110125784A CN112798377A CN 112798377 A CN112798377 A CN 112798377A CN 202110125784 A CN202110125784 A CN 202110125784A CN 112798377 A CN112798377 A CN 112798377A
- Authority
- CN
- China
- Prior art keywords
- fluorescence
- fluorescence quenching
- parts
- tissue slice
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000010791 quenching Methods 0.000 title claims abstract description 48
- 230000000171 quenching effect Effects 0.000 title claims abstract description 48
- 238000011084 recovery Methods 0.000 title claims abstract description 30
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 33
- 239000008055 phosphate buffer solution Substances 0.000 claims abstract description 24
- 239000000243 solution Substances 0.000 claims abstract description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 10
- 238000005406 washing Methods 0.000 claims abstract description 8
- 238000010166 immunofluorescence Methods 0.000 abstract description 15
- 238000002474 experimental method Methods 0.000 abstract description 12
- 238000000034 method Methods 0.000 abstract description 3
- 238000003018 immunoassay Methods 0.000 abstract description 2
- 230000000694 effects Effects 0.000 description 14
- 239000007850 fluorescent dye Substances 0.000 description 6
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical group C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- BFMYDTVEBKDAKJ-UHFFFAOYSA-L disodium;(2',7'-dibromo-3',6'-dioxido-3-oxospiro[2-benzofuran-1,9'-xanthene]-4'-yl)mercury;hydrate Chemical compound O.[Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C([O-])C([Hg])=C1OC1=C2C=C(Br)C([O-])=C1 BFMYDTVEBKDAKJ-UHFFFAOYSA-L 0.000 description 3
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical group O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- JGVWCANSWKRBCS-UHFFFAOYSA-N tetramethylrhodamine thiocyanate Chemical compound [Cl-].C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=C(SC#N)C=C1C(O)=O JGVWCANSWKRBCS-UHFFFAOYSA-N 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 2
- 238000004043 dyeing Methods 0.000 description 2
- -1 AF555 Chemical compound 0.000 description 1
- 208000035977 Rare disease Diseases 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/34—Purifying; Cleaning
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/533—Production of labelled immunochemicals with fluorescent label
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
- G01N2001/302—Stain compositions
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
- G01N2021/6432—Quenching
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P10/00—Technologies related to metal processing
- Y02P10/20—Recycling
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Optics & Photonics (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Abstract
本发明公开了一种荧光淬灭恢复剂及其应用,涉及免疫分析和生物技术应用领域,按体积份数计,由下列组分组成:35‑45份无水乙醇,55‑65份PBS溶液,荧光淬灭恢复剂的应用,包括如下步骤:A1:使用PBS溶液清洗荧光淬灭的组织切片或细胞样本,清洗次数为1‑2次,每次5min;A2:在组织切片或细胞样本上滴加所述的荧光淬灭恢复剂,室温孵育10min;A3:用PBS溶液清洗组织切片或细胞样本3次,每次5min,得到荧光淬灭恢复后的组织切片或细胞样本。可在荧光淬灭的免疫荧光样本上重新染色,保证重新染色免疫荧光样本的荧光能很好的显示,能增加免疫荧光实验的容错率,节约样本数量,节省实验时间。
Description
技术领域
本发明涉及免疫分析和生物技术应用领域,具体涉及一种荧光淬灭恢复剂及其应用。
背景技术
免疫荧光常常是一次性的,即一次实验后马上用荧光显微镜或者激光共聚焦观察。但免疫荧光孵育荧光二抗后如果操作失误,例如,照射白光或者其他原因引起荧光淬灭,现有技术只能通过重新实验来弥补失误。如果实验样品珍贵,例如,少见疾病的组织样本或者需要长时间造模得到的实验样本,常常没有多余样本用于犯错。同时,对于珍贵的样本,想用免疫荧光检测多个指标,而现有免疫荧光技术最多只能检测五种颜色,还要受限于检测仪器的检测通道个数,这就导致需要的样本量增加,延长实验时间。
发明内容
本发明针对现有技术存在的问题,提供了一种荧光淬灭恢复剂及其应用,可在荧光淬灭的免疫荧光样本上重新染色,保证重新染色免疫荧光样本的荧光能很好的显示,能增加免疫荧光实验的容错率,节约样本数量,节省实验时间。
本发明通过下述技术方案实现:一种荧光淬灭恢复剂,按体积份数计,由下列组分组成:35-45份无水乙醇,55-65份PBS溶液。
进一步,根据权利要求1所述的一种荧光淬灭恢复剂,按体积份数计,由下列组分组成:40份无水乙醇,60份PBS溶液。
一种荧光淬灭恢复剂的应用,包括如下步骤:
A1:使用PBS溶液清洗荧光淬灭的组织切片或细胞样本,清洗次数为1-2次,每次5min;
A2:在组织切片或细胞样本上滴加所述的荧光淬灭恢复剂,室温孵育10min;
A3:用PBS溶液清洗组织切片或细胞样本3次,每次5min,得到荧光淬灭恢复后的组织切片或细胞样本。
上述至少包括以下优点:
1、本发明一种荧光淬灭恢复剂及其应用,可在荧光淬灭的免疫荧光样本上重新染色,保证重新染色免疫荧光样本的荧光能很好的显示,能增加免疫荧光实验的容错率,节约样本数量,节省实验时间;
2、本发明一种荧光淬灭恢复剂及其应用,对于一些样本需要二次拍照和检测的样本,荧光较弱,可通过荧光淬灭恢复剂的应用获得荧光增强的效果。
附图说明
此处所说明的附图用来提供对本发明实施例的进一步理解,构成本申请的一部分,并不构成对本发明实施例的限定。在附图中:
图1为荧光淬灭恢复剂的使用效果图;
图2为AF488组荧光染料的样本使用荧光淬灭恢复剂后效果图;
图3为FITC组荧光染料的样本使用荧光淬灭恢复剂后效果图;
图4为AF555组荧光染料的样本使用荧光淬灭恢复剂后效果图;
图5为TRITC组荧光染料的样本使用荧光淬灭恢复剂后效果图;
图6为CY3组荧光染料的样本使用荧光淬灭恢复剂后效果图;
图7为AF647组荧光染料的样本使用荧光淬灭恢复剂后效果图;
图8为DAPI组荧光染料的样本使用荧光淬灭恢复剂后效果图;
图9为Hoechst组荧光染料的样本使用荧光淬灭恢复剂后效果图。
具体实施方式
为使本发明的目的、技术方案和优点更加清楚明白,下面结合实施例和附图,对本发明作进一步的详细说明,本发明的示意性实施方式及其说明仅用于解释本发明,并不作为对本发明的限定。
实施例
在一个实施例中,一种荧光淬灭恢复剂,按体积份数计,由下列组分组成:35-45份无水乙醇,55-65份PBS溶液。
在一个实施例中,一种荧光淬灭恢复剂,按体积份数计,由下列组分组成:40份无水乙醇,60份PBS溶液。
在一个实施例中,一种荧光淬灭恢复剂,按体积份数计,由下列组分组成:35份无水乙醇,55份PBS溶液。
在一个实施例中,一种荧光淬灭恢复剂,按体积份数计,由下列组分组成:45份无水乙醇,65份PBS溶液。
在一个实施例中,将无水乙醇和PBS溶液充分混合制得荧光淬灭恢复剂。
在一个实施例中,一种荧光淬灭恢复剂的应用,包括如下步骤:
A1:使用PBS溶液清洗荧光淬灭的组织切片或细胞样本,清洗次数为1-2次,每次5min;
A2:在组织切片或细胞样本上滴加所述的荧光淬灭恢复剂,室温孵育10min;
A3:用PBS溶液清洗组织切片或细胞样本3次,每次5min,得到荧光淬灭恢复后的组织切片或细胞样本。
实验例
荧光淬灭恢复效果实验:如图1所示,图1(a)为原始样本,原始样本为免疫荧光孵育荧光二抗后的样本,将图1(a)分成两组,分别用紫外线照射2小时进行处理,处理后并分别滴加PBS缓冲液和本发明荧光淬灭恢复剂,图1(b)即为滴加PBS缓冲液的对照组,图1(c)为滴加本发明荧光淬灭恢复剂的处理组,处理组应用荧光淬灭恢复剂的方法如实施例所述。由图可以看出,本发明荧光淬灭恢复剂能够对荧光淬灭的样本进行有效恢复。
不同组荧光染料的样本恢复效果实验:根据荧光染料的品牌不同,设立7个小组,分别为AF488组、FITC组、AF555组、TRITC组、CY3组、AF647组、DAPI组和Hoechst组,如图2-9,七个小组样本为免疫荧光孵育荧光二抗后的样本,淬灭后用本发明荧光淬灭恢复剂进行处理,处理方法如实施例所述,处理效果如图2-9所示。由图可知,AF488组、FITC组、AF555组、TRITC组、CY3组、AF647组淬灭恢复效果明显,DAPI组和Hoechst组淬灭恢复效果稍弱;恢复后的荧光强度达到最初的荧光强度的50%-80%左右;恢复后的荧光强度相比淬灭后的荧光强度能够提高2-5倍。
以上所述的具体实施方式,对本发明的目的、技术方案和有益效果进行了进一步详细说明,所应理解的是,以上所述仅为本发明的具体实施方式而已,并不用于限定本发明的保护范围,凡在本发明的精神和原则之内,所做的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。
Claims (3)
1.一种荧光淬灭恢复剂,其特征在于,按体积份数计,由下列组分组成:35-45份无水乙醇,55-65份PBS溶液。
2.根据权利要求1所述的一种荧光淬灭恢复剂,其特征在于,按体积份数计,由下列组分组成:40份无水乙醇,60份PBS溶液。
3.一种荧光淬灭恢复剂的应用,其特征在于,包括如下步骤:
A1:使用PBS溶液清洗荧光淬灭的组织切片或细胞样本,清洗次数为1-2次,每次5min;
A2:在组织切片或细胞样本上滴加如权利要求1所述的荧光淬灭恢复剂,室温孵育10min;
A3:用PBS溶液清洗组织切片或细胞样本3次,每次5min,得到荧光淬灭恢复后的组织切片或细胞样本。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110125784.0A CN112798377B (zh) | 2021-01-29 | 2021-01-29 | 一种荧光淬灭恢复剂及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110125784.0A CN112798377B (zh) | 2021-01-29 | 2021-01-29 | 一种荧光淬灭恢复剂及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112798377A true CN112798377A (zh) | 2021-05-14 |
CN112798377B CN112798377B (zh) | 2023-03-17 |
Family
ID=75812828
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110125784.0A Active CN112798377B (zh) | 2021-01-29 | 2021-01-29 | 一种荧光淬灭恢复剂及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112798377B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115112656A (zh) * | 2022-07-08 | 2022-09-27 | 四川大学华西医院 | 一种结合免疫荧光染色的黏膜淋巴管整体成像的方法 |
CN116990101A (zh) * | 2023-09-27 | 2023-11-03 | 四川大学华西医院 | 一种易掉片组织的预处理方法及其多重免疫荧光染色方法 |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101639441A (zh) * | 2008-08-01 | 2010-02-03 | 中国科学院海洋研究所 | 一种用于海水双壳类减数分裂器的免疫荧光显微观察方法 |
CN101646458A (zh) * | 2007-02-01 | 2010-02-10 | 健泰科生物技术公司 | 使用血管发生抑制剂的联合疗法 |
CN101802013A (zh) * | 2007-07-16 | 2010-08-11 | 健泰科生物技术公司 | 人源化抗cd79b抗体和免疫偶联物及使用方法 |
WO2011091086A1 (en) * | 2010-01-19 | 2011-07-28 | Sirigen Inc. | Novel reagents for directed biomarker signal amplification |
CN105062465A (zh) * | 2015-07-31 | 2015-11-18 | 山东大学 | 一类环境敏感型的α1-肾上腺素能受体近红外荧光配体及其应用 |
CN107727844A (zh) * | 2017-11-18 | 2018-02-23 | 安徽师范大学 | 一种荧光免疫定量检测mfap纳米药物载体的方法 |
CN109298174A (zh) * | 2018-09-26 | 2019-02-01 | 姜云瀚 | 一种多色免疫荧光标记方法和成像方法 |
CN110179981A (zh) * | 2019-06-18 | 2019-08-30 | 四川大学华西医院 | 一种线性-树状给药系统及其制备方法和用途 |
CN110632292A (zh) * | 2019-06-12 | 2019-12-31 | 江苏莱尔生物医药科技有限公司 | 一种检测pd-l1和cd8抗原的免疫荧光试剂盒及应用方法 |
CN111811909A (zh) * | 2020-07-01 | 2020-10-23 | 北京基谱生物科技有限公司 | 一种组织自发荧光淬灭剂的制备及应用 |
CN112179879A (zh) * | 2019-07-02 | 2021-01-05 | 南京工业大学 | 一种左多巴纳米颗粒的制备方法及其生物传感应用 |
-
2021
- 2021-01-29 CN CN202110125784.0A patent/CN112798377B/zh active Active
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101646458A (zh) * | 2007-02-01 | 2010-02-10 | 健泰科生物技术公司 | 使用血管发生抑制剂的联合疗法 |
CN101802013A (zh) * | 2007-07-16 | 2010-08-11 | 健泰科生物技术公司 | 人源化抗cd79b抗体和免疫偶联物及使用方法 |
CN101639441A (zh) * | 2008-08-01 | 2010-02-03 | 中国科学院海洋研究所 | 一种用于海水双壳类减数分裂器的免疫荧光显微观察方法 |
WO2011091086A1 (en) * | 2010-01-19 | 2011-07-28 | Sirigen Inc. | Novel reagents for directed biomarker signal amplification |
CN105062465A (zh) * | 2015-07-31 | 2015-11-18 | 山东大学 | 一类环境敏感型的α1-肾上腺素能受体近红外荧光配体及其应用 |
CN107727844A (zh) * | 2017-11-18 | 2018-02-23 | 安徽师范大学 | 一种荧光免疫定量检测mfap纳米药物载体的方法 |
CN109298174A (zh) * | 2018-09-26 | 2019-02-01 | 姜云瀚 | 一种多色免疫荧光标记方法和成像方法 |
CN110632292A (zh) * | 2019-06-12 | 2019-12-31 | 江苏莱尔生物医药科技有限公司 | 一种检测pd-l1和cd8抗原的免疫荧光试剂盒及应用方法 |
CN110179981A (zh) * | 2019-06-18 | 2019-08-30 | 四川大学华西医院 | 一种线性-树状给药系统及其制备方法和用途 |
CN112179879A (zh) * | 2019-07-02 | 2021-01-05 | 南京工业大学 | 一种左多巴纳米颗粒的制备方法及其生物传感应用 |
CN111811909A (zh) * | 2020-07-01 | 2020-10-23 | 北京基谱生物科技有限公司 | 一种组织自发荧光淬灭剂的制备及应用 |
Non-Patent Citations (5)
Title |
---|
KIM IJ ET AL: "Spectroscopic Analysis of Fe Ion-Induced Fluorescence Quenching of the Green Fluorescent Protein ZsGreen" * |
ZHANG LD ET AL: "Selective and sensitive detection and detoxification of Pd2+ in living cells with a water-soluble fluorescent probe" * |
全国卫生专业技术资格考试专家委员会: "《卫生专业技术资格考试指导 临床医学检验(上)》", 28 February 2004 * |
杨启文等: "临床微生物实验室真菌检测能力建设基本要求专家共识" * |
温书恒等: "小鼠骨骼肌挫伤修复过程中周细胞数量变化及其与损伤时间相关性" * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115112656A (zh) * | 2022-07-08 | 2022-09-27 | 四川大学华西医院 | 一种结合免疫荧光染色的黏膜淋巴管整体成像的方法 |
CN116990101A (zh) * | 2023-09-27 | 2023-11-03 | 四川大学华西医院 | 一种易掉片组织的预处理方法及其多重免疫荧光染色方法 |
CN116990101B (zh) * | 2023-09-27 | 2023-12-15 | 四川大学华西医院 | 一种易掉片组织的预处理方法及其多重免疫荧光染色方法 |
Also Published As
Publication number | Publication date |
---|---|
CN112798377B (zh) | 2023-03-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112798377B (zh) | 一种荧光淬灭恢复剂及其应用 | |
Sun et al. | A whole-brain map of long-range inputs to GABAergic interneurons in the mouse medial prefrontal cortex | |
Fuzik et al. | Integration of electrophysiological recordings with single-cell RNA-seq data identifies neuronal subtypes | |
Yuan et al. | PLD3 affects axonal spheroids and network defects in Alzheimer’s disease | |
Rey et al. | Mitochondrial RNA granules are fluid condensates positioned by membrane dynamics | |
Strettoi et al. | The number of unidentified amacrine cells in the mammalian retina | |
Rocco et al. | Markedly lower glutamic acid decarboxylase 67 protein levels in a subset of boutons in schizophrenia | |
Sung et al. | Simplified three-dimensional tissue clearing and incorporation of colorimetric phenotyping | |
Silvestri et al. | Universal autofocus for quantitative volumetric microscopy of whole mouse brains | |
WO2016108359A1 (ko) | 조직 투명화 방법 | |
Wang et al. | Chemical sectioning fluorescence tomography: high-throughput, high-contrast, multicolor, whole-brain imaging at subcellular resolution | |
CN110308031A (zh) | 一种稳定的真菌荧光染色液 | |
CN104155160A (zh) | 一种不含苯的组织脱蜡透明剂 | |
Yu et al. | Development of the mouse and human cochlea at single cell resolution | |
Zheng et al. | Review of micro-optical sectioning tomography (MOST): technology and applications for whole-brain optical imaging | |
Fish et al. | Laminar distribution of subsets of GABAergic axon terminals in human prefrontal cortex | |
Heiple et al. | pH changes in pinosomes and phagosomes in the ameba, Chaos carolinensis. | |
Zhang et al. | Use of TAI-FISH to visualize neural ensembles activated by multiple stimuli | |
Tehrani et al. | Two-photon deep-tissue spatially resolved mitochondrial imaging using membrane potential fluorescence fluctuations | |
Gurdita et al. | InVision: An optimized tissue clearing approach for three-dimensional imaging and analysis of intact rodent eyes | |
Currens et al. | Evaluation and optimization of PolyJet 3D-printed materials for cell culture studies | |
Wu et al. | Age related extracellular matrix and interstitial cell phenotype in pulmonary valves | |
Sicherman et al. | Estimating and correcting for off-target cellular contamination in brain cell type specific RNA-seq data | |
Constantinople et al. | Quantitative analysis of neurons with Kv3 potassium channel subunits, Kv3. 1b and Kv3. 2, in macaque primary visual cortex | |
Woo et al. | A modified magnified analysis of proteome (MAP) method for super-resolution cell imaging that retains fluorescence |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |